Metagenomi Therapeutics, Inc.
 logo

Metagenomi Therapeutics, Inc. Cash Flow Statement

Operating, investing, and financing cash movements
Market Cap$52.3M

No metrics found for this filter.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.